The Follicular Output Rate (FORT) as a method to evaluate transdermal testosterone efficacy in poor responders.

Autor:	Solernou R; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain., Peralta S; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain., Casals G; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain., Guimera M; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain., Solsona M; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain., Borras A; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain., Manau D; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain., Fàbregues F; Institute Clinic of Gynecology, Obstetrics and Gynecology. Hospital Clinic. Barcelona, Spain.
Jazyk:	angličtina
Zdroj:	JBRA assisted reproduction [JBRA Assist Reprod] 2021 Apr 27; Vol. 25 (2), pp. 229-234. Date of Electronic Publication: 2021 Apr 27.
DOI:	10.5935/1518-0557.20200086
Abstrakt:	Objective: Follicular Output Rate (FORT) is an efficient quantitative and qualitative marker of ovarian responsiveness to gonadotropins. Transdermal testosterone (TT) has been used as adjuvant therapy to gonadotrophins in order to improve ovarian response in poor responders (PR). The aim of this study was to analyze whether TT can improve follicular sensitivity to gonadotropins using FORT. Methods: This retrospective study, held in a tertiary-care university hospital included 90 PR patients, according to the Bologna criteria. Patients in Group 1 (n = 46) received transdermal application of testosterone preceding gonadotrophin ovarian stimulation under pituitary suppression. In Group 2 (n = 44) ovarian stimulation was carried out with high-dose gonadotrophin in association with minidose GnRH agonist protocol. We analyzed ovarian stimulation parameters and IVF outcomes. We determined antral follicle count (AFC) (3-8 mm) before ovarian stimulation, pre-ovulatory follicle count (PFC) (16-22 mm) and the day of hCG administration. We calculated the FORT using the PFCx100/AFC ratio. Results: Baseline characteristics and ovarian reserve parameters were similar in both groups. FORT and oocytes retrieved were significantly higher in group 1 vs group 2. There were no significant differences in pregnancy rates. In group 1 there was a significant correlation between FORT and AFC. Conclusions: This study suggests that the potential beneficial mechanism of TT in poor responder patients may be based on increasing the antral follicle sensitivity to gonadotrophin. FORT is an excellent tool to demonstrate this.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu